Cardiac enzymes after transmyocardial laser treatment with CO2 laser.
OBJECTIVE
The aim of the present study was to examine postoperative serum levels of cardiac enzymes after transmyocardial laser treatment (TML) and to evaluate any associations between this release, postoperative cardiac events and change in ejection fraction after 3 months' follow-up.


METHODS
Forty-nine patients with angina pectoris Canadian Cardiovascular Society Angina Score Class III & IV refractory to medical therapy and untreatable by coronary artery bypass or percutaneous transluminal angioplasty treated with CO2 laser were included. Inclusion criteria were age less than 75 years, left ventricular ejection fraction greater than or equal to 30% and myocardial regions with reversible ischemia. Serum levels of aspartate aminotranspherase (ASAT), alanine aminotranspherase (ALAT) and MB-isoenzymes of creatine kinase (CK-MB) were followed during the first 72 h after surgery. Ejection fractions were estimated by multiple-gated acquisition ventriculography at inclusion and 3 months postoperatively.


RESULTS
A significant increase in serum markers of myocardial necrosis was observed 8 h after surgery. A subsequent increase from 8 to 24 h after surgery was associated with the presence of postoperative cardiac adverse events. An inverse correlation was found between peak level of cardiac enzymes and change in ejection fraction from baseline to 3 months' follow-up.


CONCLUSIONS
TML with CO2 laser is followed by a significant increase in serum levels of cardiac enzymes after 8 h. Further significant increases are associated with cardiac adverse events postoperatively. Peak enzyme values are inversely correlated with change in ejection fraction from baseline to 3 months' follow-up.
Tjomsland
O
O
Feiring Heart Clinic, University of Oslo, Norway. mrisberg@ah.telia.no
Aaberge
L
L
Almdahl
S M
SM
Moelstad
P
P
Rootwelt
K
K
Nordstrand
K
K
Saatvedt
K
K
D000787:Angina Pectoris / Q000097:blood* / Q000201:enzymology* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D053685:Laser Therapy; D008297:Male; D009203:Myocardial Infarction / Q000097:blood / Q000201:enzymology; D009204:Myocardial Revascularization; D011184:Postoperative Period; D013318:Stroke Volume / Q000502:physiology; D014166:Transferases / Q000097:blood
D007527:Isoenzymes; D014166:Transferases